Stock index futures fell on Thursday, as jobless claims fell and GDP was revised higher in the third estimate. Here are four stocks to watch on the day:
Novo Nordisk (NVO) shares will be keenly watched as the company is set to post five consecutive days of losses. The firm is currently down 2.8% in premarket trade. Earlier in September, it was reported that the company had laid off its U.S. sales team focused on obesity and diabetes education for healthcare providers as part of broader restructuring under new CEO Maziar Mike Doustdar.
Starbucks (SBUX) stock rose 0.1% before the opening bell as its board approved a restructuring plan involving the closure of coffeehouses and the further transformation of the company’s support organization. The Seattle-based company estimates that it will incur approximately $1 billion related to the store closures, support organization transformation, and other restructuring activities. It also plans to cut about 900 jobs in its support teams and close many open positions.
Accenture (ACN) was down 4.4% in extended trading, even after the firm beat both its top and bottom line estimates in its fourth quarter. The firm expects full-year revenue growth of 2% to 5% in local currency, vs. estimated growth of 5.28% Y/Y. The company sees its full-year adjusted EPS of $13.52 to $13.90 vs. a consensus of $13.79.
Eli Lilly (LLY) stock was down 0.4% in premarket trade as the firm halted a phase 2a study examining bimagrumab, a drug to prevent muscle wasting, a common issue with quick weight loss, in combination with its obesity drug Zepbound.